Compare ACHV & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACHV | CPSS |
|---|---|---|
| Founded | N/A | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6M | 191.4M |
| IPO Year | N/A | 1992 |
| Metric | ACHV | CPSS |
|---|---|---|
| Price | $4.65 | $8.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 653.5K | 22.0K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | ★ $196,531,000.00 |
| Revenue This Year | N/A | $143.76 |
| Revenue Next Year | N/A | $14.32 |
| P/E Ratio | ★ N/A | $10.86 |
| Revenue Growth | N/A | ★ 6.67 |
| 52 Week Low | $1.84 | $6.67 |
| 52 Week High | $5.78 | $12.73 |
| Indicator | ACHV | CPSS |
|---|---|---|
| Relative Strength Index (RSI) | 52.84 | 58.11 |
| Support Level | $4.45 | $8.03 |
| Resistance Level | $5.19 | $8.29 |
| Average True Range (ATR) | 0.32 | 0.27 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 58.97 | 88.07 |
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.